These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Contrast-enhanced ultrasound for assessment of therapeutic response after percutaneous radiofrequency ablation of small renal tumors. Garbajs M; Popovic P J BUON; 2016; 21(3):685-90. PubMed ID: 27569091 [TBL] [Abstract][Full Text] [Related]
4. Contrast enhanced ultrasound in the evaluation and percutaneous treatment of hepatic and renal tumors. Meloni MF; Smolock A; Cantisani V; Bezzi M; D'Ambrosio F; Proiti M; Lee F; Aiani L; Calliada F; Ferraioli G Eur J Radiol; 2015 Sep; 84(9):1666-74. PubMed ID: 26094868 [TBL] [Abstract][Full Text] [Related]
5. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Zhao X; Wang W; Zhang S; Liu J; Zhang F; Ji C; Li X; Gan W; Zhang G; Guo H Abdom Imaging; 2012 Oct; 37(5):885-91. PubMed ID: 22131041 [TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced sonography of the kidney. Setola SV; Catalano O; Sandomenico F; Siani A Abdom Imaging; 2007; 32(1):21-8. PubMed ID: 17420958 [TBL] [Abstract][Full Text] [Related]
7. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique? Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801 [TBL] [Abstract][Full Text] [Related]
8. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909 [TBL] [Abstract][Full Text] [Related]
9. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202 [TBL] [Abstract][Full Text] [Related]
10. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560 [TBL] [Abstract][Full Text] [Related]
11. Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: an open-label, randomized, comparative pilot trial. Chen Y; Huang J; Xia L; Dong B; Chen W; Xue W; Liu D; Huang Y J Endourol; 2013 Jun; 27(6):697-704. PubMed ID: 23442174 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous ultrasound-guided radiofrequency ablation for kidney tumors in patients with surgical risk. Salagierski M; Salagierski M; Salagierska-Barwińska A; Sosnowski M Int J Urol; 2006 Nov; 13(11):1375-9. PubMed ID: 17083386 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940 [TBL] [Abstract][Full Text] [Related]